An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice ...
Cancer immunotherapies, such as immune checkpoint inhibitors (ICIs), are effective against many types of cancer. However, these treatments don’t work well for some tumors, including ovarian cancer (OC ...